229 related articles for article (PubMed ID: 18405488)
21. An odd case of heteroallelic acute intermittent porphyria in the Argentinean population.
Piñeiro Pauwels MB; Gerez EN; Martinez MC; Melito VA; Parera VE; Batlle A; Rossetti MV
Cell Mol Biol (Noisy-le-grand); 2013 Mar; 59 Suppl():OL1855-60. PubMed ID: 23522335
[TBL] [Abstract][Full Text] [Related]
22. CRIM-positive mutations of acute intermittent porphyria in Finland.
Kauppinen R; Peltonen L; Pihlaja H; Mustajoki P
Hum Mutat; 1992; 1(5):392-6. PubMed ID: 1301948
[TBL] [Abstract][Full Text] [Related]
23. Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France.
Nordmann Y; Puy H; Da Silva V; Simonin S; Robreau AM; Bonaiti C; Phung LN; Deybach JC
J Intern Med; 1997 Sep; 242(3):213-7. PubMed ID: 9350165
[TBL] [Abstract][Full Text] [Related]
24. Acute intermittent porphyria and mental illness--a family study.
Patience DA; Blackwood DH; McColl KE; Moore MR
Acta Psychiatr Scand; 1994 Apr; 89(4):262-7. PubMed ID: 8023693
[TBL] [Abstract][Full Text] [Related]
25. [Acute intermittent porphyria associated with hyperaldosteronism and inappropriate antidiuretic hormone secretion syndrome].
Frère T; Roy-Peaud F; Ripault MP; Dumas P; Silvain C; Pourrat O; Beauchant M
Gastroenterol Clin Biol; 1998; 22(8-9):727-31. PubMed ID: 9823563
[TBL] [Abstract][Full Text] [Related]
26. Many pitfalls in diagnosis of acute intermittent porphyria: a case report.
Indika NLR; Kesavan T; Dilanthi HW; Jayasena KLSPKM; Chandrasiri NDPD; Jayasinghe IN; Piumika UMT; Vidanapathirana DM; Gunarathne KDAV; Dissanayake M; Jasinge E; Arachchi WK; Doheny D; Desnick RJ
BMC Res Notes; 2018 Aug; 11(1):552. PubMed ID: 30071891
[TBL] [Abstract][Full Text] [Related]
27. A novel mutation in the porphobilinogen deaminase gene in an extended Chinese family with acute intermittent porphyria.
Yang J; Wang H; Yin K; Hua B; Zhu T; Zhao Y; Guo S; Yu X; Wu W; Zhou Z
Gene; 2015 Jul; 565(2):288-90. PubMed ID: 25870942
[TBL] [Abstract][Full Text] [Related]
28. Genetic investigation of the porphobilinogen deaminase gene in Swedish acute intermittent porphyria families.
Lundin G; Lee JS; Thunell S; Anvret M
Hum Genet; 1997 Jul; 100(1):63-6. PubMed ID: 9225970
[TBL] [Abstract][Full Text] [Related]
29. Acute intermittent porphyria caused by a G to C mutation in exon 12 of the porphobilinogen deaminase gene that results in exon skipping.
Daimon M; Yamatani K; Igarashi M; Fukase N; Ogawa A; Tominaga M; Sasaki H
Hum Genet; 1993 Dec; 92(6):549-53. PubMed ID: 8262514
[TBL] [Abstract][Full Text] [Related]
30. Novel human pathological mutations. Gene symbol: HMBS. Disease: porphyria, acute intermittent.
Douderova DU; Zeman J; Martasek P
Hum Genet; 2010 Apr; 127(4):477. PubMed ID: 21488288
[No Abstract] [Full Text] [Related]
31. Molecular basis of acute intermittent porphyria.
Wood S; Lambert R; Jordan PM
Mol Med Today; 1995 Aug; 1(5):232-9. PubMed ID: 17607885
[TBL] [Abstract][Full Text] [Related]
32. Identification of acute intermittent porphyria carriers by molecular biologic methods.
Bor M; Balogh K; Pusztai A; Tasnádi G; Hunyady L
Acta Physiol Hung; 1999; 86(2):147-53. PubMed ID: 10741873
[TBL] [Abstract][Full Text] [Related]
33. The W198X and R173W mutations in the porphobilinogen deaminase gene in acute intermittent porphyria have higher clinical penetrance than R167W. A population-based study.
Andersson C; Floderus Y; Wikberg A; Lithner F
Scand J Clin Lab Invest; 2000 Nov; 60(7):643-8. PubMed ID: 11202057
[TBL] [Abstract][Full Text] [Related]
34. A point mutation, C to T, in exon 8 of the porphobilinogen deaminase gene in a Japanese family with acute intermittent porphyria.
Morita Y; Daimon M; Kashiwaba M; Yamatani K; Igarashi M; Fukase N; Ohnuma H; Ikezawa Y; Sugiyama K; Manaka H
Jpn J Hum Genet; 1995 Jun; 40(2):207-13. PubMed ID: 7663002
[TBL] [Abstract][Full Text] [Related]
35. Red blood cell porphobilinogen deaminase in the evaluation of acute intermittent porphyria.
Pierach CA; Weimer MK; Cardinal RA; Bossenmaier IC; Bloomer JR
JAMA; 1987 Jan; 257(1):60-1. PubMed ID: 3783903
[TBL] [Abstract][Full Text] [Related]
36. Acute intermittent porphyria caused by an arginine to histidine substitution (R26H) in the cofactor-binding cleft of porphobilinogen deaminase.
Llewellyn DH; Whatley S; Elder GH
Hum Mol Genet; 1993 Aug; 2(8):1315-6. PubMed ID: 8401516
[No Abstract] [Full Text] [Related]
37. Novel human pathological mutations. Gene symbol: HMBS. Disease: porphyria, acute intermittent.
Di Pierro E; Besana V; Brancaleoni V; Fasulo MR; Cesaretti C; Cappellini MD
Hum Genet; 2009 Apr; 125(3):347. PubMed ID: 19320027
[No Abstract] [Full Text] [Related]
38. De Novo mutation found in the porphobilinogen deaminase gene in Slovak acute intermittent porphyria patient: molecular biochemical study.
Ulbrichova D; Flachsova E; Hrdinka M; Saligova J; Bazar J; Raman CS; Martasek P
Physiol Res; 2006; 55 Suppl 2():S145-154. PubMed ID: 17298218
[TBL] [Abstract][Full Text] [Related]
39. A novel 12-base pair deletion mutation in exon 15 of the porphobilinogen deaminase gene in a Taiwanese patient with acute intermittent porphyria.
Sakabe J; Susa S; Daimon M; Lan MY; Kato T
Blood Cells Mol Dis; 2008; 41(2):202. PubMed ID: 18554962
[No Abstract] [Full Text] [Related]
40. Homozygous acute intermittent porphyria in a 7-year-old boy with massive excretions of porphyrins and porphyrin precursors.
Hessels J; Voortman G; van der Wagen A; van der Elzen C; Scheffer H; Zuijderhoudt FM
J Inherit Metab Dis; 2004; 27(1):19-27. PubMed ID: 14970743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
